|
Volumn 24, Issue 4, 2014, Pages 217-224
|
Quality of life in patients with persistent allergic rhinitis treated with desloratadine monotherapy or desloratadine plus montelucast combination
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETIC ACID DERIVATIVE;
ANTIASTHMATIC AGENT;
DESLORATADINE;
HISTAMINE H1 RECEPTOR ANTAGONIST;
LEUKOTRIENE RECEPTOR BLOCKING AGENT;
LORATADINE;
MONTELUKAST;
QUINOLINE DERIVATIVE;
ADOLESCENT;
ADULT;
ANALOGS AND DERIVATIVES;
CONTROLLED STUDY;
CROSS-SECTIONAL STUDY;
DOUBLE BLIND PROCEDURE;
DRUG COMBINATION;
FEMALE;
HUMAN;
MALE;
ORAL DRUG ADMINISTRATION;
PSYCHOLOGY;
QUALITY OF LIFE;
QUESTIONNAIRE;
RANDOMIZED CONTROLLED TRIAL;
RHINITIS, ALLERGIC, PERENNIAL;
TREATMENT OUTCOME;
YOUNG ADULT;
ACETATES;
ADMINISTRATION, ORAL;
ADOLESCENT;
ADULT;
ANTI-ASTHMATIC AGENTS;
CROSS-SECTIONAL STUDIES;
DOUBLE-BLIND METHOD;
DRUG THERAPY, COMBINATION;
FEMALE;
HISTAMINE H1 ANTAGONISTS, NON-SEDATING;
HUMANS;
LEUKOTRIENE ANTAGONISTS;
LORATADINE;
MALE;
QUALITY OF LIFE;
QUESTIONNAIRES;
QUINOLINES;
RHINITIS, ALLERGIC, PERENNIAL;
TREATMENT OUTCOME;
YOUNG ADULT;
|
EID: 84944148094
PISSN: 13007475
EISSN: None
Source Type: Journal
DOI: 10.5606/kbbihtisas.2014.48108 Document Type: Article |
Times cited : (10)
|
References (0)
|